🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study will explore the immunogenicity of AVAXIM™ 80U-Pediatric ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00313950
To evaluate the immunogenicity, lot-to-lot consistency and safety of three ...
Status
Completed
Location
Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2021-12-23
Trial ID
NCT05161845
Treatments Being Tested
Hepatitis A vaccine will be given either alone or together with measles, mu...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00312858
The purpose of this study is to evaluate the safety and immunogenicity of c...
Status
Completed
Location
Hanbin District Center for Disease Control and Prevention
Start Date
2019-07-26
Trial ID
NCT04111432
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rube...
Status
Completed
Location
Multiple Locations
Start Date
2007-03-26
Trial ID
NCT00326183
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
The objective of this randomized clinical trial is to test whether administ...
Status
Completed
Location
Clinical and Translational Research Center
Start Date
2020-09-22
Trial ID
NCT04475081
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
The purpose of this study is to assess the consistency of immune response t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-01-10
Trial ID
NCT06740630